Home> Products> liver toxicity

{ "products": [ { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "685bf1b58f1119e73c154485", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "REBAMPEE OTIC", "description": "REBAMPEE OTIC is an advanced nutraceutical formulation combining rebamipide, alpha lipoic acid, and acetylcysteine, uniquely designed to support inner ear health and manage age-related hearing loss. The synergistic combination of these three active ingredients works to reduce oxidative stress, prevent cellular degeneration, and support nerve function, offering a targeted solution in cases where oxidative damage contributes to auditory decline. The formulation, known as rebamipide alpha 100mg lipoic acid 100mg and acetylcysteine 100mg capsules, is gaining attention in otolaryngology as a supportive therapy for managing sensorineural and degenerative hearing conditions.\n\nWhat is REBAMPEE OTIC?\nREBAMPEE OTIC is a capsule formulation composed of three clinically significant ingredients:\n\nRebamipide (100 mg): Known for its mucosal protective and antioxidant properties, it plays a role in reducing inflammation and protecting the delicate inner ear structures from oxidative damage.\n\nAlpha Lipoic Acid (100 mg): A powerful antioxidant that supports nerve regeneration and protects against cellular degeneration in the cochlea and auditory pathways.\n\nAcetylcysteine (100 mg): An effective mucolytic and precursor to glutathione, it combats oxidative stress and may help reduce cochlear damage due to noise, drugs, or aging.\n\nTogether, they act to protect and rejuvenate auditory cells, making REBAMPEE OTIC a promising aid in the treatment and management of age-related hearing loss and oxidative stress-induced otological damage.\n\nUses of REBAMPEE OTIC\nUsed in the treatment of age-related hearing loss (presbycusis)\n\nHelps protect auditory nerve cells from oxidative damage\n\nSupports cochlear and inner ear health in degenerative auditory conditions\n\nMay aid in managing hearing impairment due to noise exposure or ototoxic medications\n\nPromotes antioxidant activity and inner ear cellular regeneration\n\nPossible Side Effects\nMost people tolerate REBAMPEE OTIC well, but some may experience mild to moderate side effects such as:\n\nNausea\n\nMild headache\n\nHeartburn\n\nDizziness\n\nAbdominal discomfort\n\nFatigue\n\nSerious Side Effects (Rare)\nIn rare cases, more severe effects may occur:\n\nAllergic reactions such as skin rash, itching, or swelling\n\nSevere abdominal pain\n\nBreathing difficulty or tightness in the chest\n\nSevere dizziness or fainting\n\nHepatic enzyme elevation or liver dysfunction\n\nSeek immediate medical attention if any serious symptoms occur.\n\nPrecautions Before Using REBAMPEE OTIC\nConsult your physician before starting if you have liver disease, kidney dysfunction, or any autoimmune condition\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor\n\nUse with caution in individuals with a known allergy to any of the ingredients\n\nAvoid excessive alcohol consumption during the course as it may increase liver stress\n\nNot to be used as a replacement for medically prescribed treatments for hearing loss without a physician’s recommendation\n\nDrug Interactions\nREBAMPEE OTIC may interact with several medications. It is important to inform your healthcare provider about all drugs you are currently taking, including supplements and herbal products.\n\nWhat drugs interact with REBAMPEE OTIC?\n\nAnticoagulants (e.g., warfarin): Alpha lipoic acid may enhance the anticoagulant effect, increasing the risk of bleeding\n\nAntidiabetic medications: May enhance the glucose-lowering effect, increasing the risk of hypoglycemia\n\nIron supplements: Acetylcysteine may interact with iron metabolism\n\nCertain antibiotics: NAC (acetylcysteine) may reduce the efficacy of some antibiotics if taken simultaneously\n\nThyroid medications: Alpha lipoic acid may interfere with thyroid hormone levels\n\nCisplatin and aminoglycoside antibiotics: When used with antioxidants like NAC, ototoxicity might be reduced, but consult your doctor for adjusted therapy\n\nAlways consult your doctor or pharmacist before combining REBAMPEE OTIC with other medications.\n\nConclusion\nREBAMPEE OTIC is a scientifically developed capsule combining rebamipide, alpha lipoic acid, and acetylcysteine, each known for its distinct cellular protective roles. When used as directed, this formula helps mitigate the effects of age-related hearing loss and supports inner ear health through potent antioxidant action. Safe, effective, and based on evidence-backed ingredients, REBAMPEE OTIC offers new hope for those experiencing the early signs of auditory decline.", "price": 280.0, "discountamount": 84.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "reduce absorption", "rebamipide 100mg", "gastrointestinal issues", "vasodilators caution", "drugs interact", "worsens consult", "liver enzymes", "promote healing", "chronic conditions", "chronic inflammation", "individuals suffering", "lasting relief", "acetylcysteine 100mgtargeting", "wellbalanced combination", "activated charcoal", "respiratory sensitivity", "breastfeeding womenonly", "kidney disorders", "precautions inform", "symptom persists", "side effects", "rare cases", "taste due", "diarrhea headache", "generally welltolerated", "burning sensation", "tingling numbness", "metabolic disorders", "oxidative stress", "ulcers reduction", "gastric mucosa", "diabetic neuropathy", "neurological protection", "oxidative damage", "powerful mucolytic", "universal antioxidant", "multifunctional capsule", "ideal adjunct", "tripleaction formulation", "neuroprotective properties", "antioxidant mucosalprotective", "cellular health", "mucosal protection", "nerve health", "healthcare provider", "medications antacids", "antioxidant agent", "rebampee otic", "starting rebampee otic", "rebampee oticrebampee otic", "medical supervision patients", "healthcare professional precautions", "acetylcysteine temporary increase", "mucosal protective agent", "medications herbal supplements", "cellular defense making", "supports nerve regeneration", "doctors dosage instructions", "optimal results follow", "simultaneously iron supplements", "dizziness skin rash", "ingredients work synergistically" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2137, "imageuri": "https://productimages.withfloats.com/actual/685bf1b95d6f047570824865.png", "tileimageuri": "https://productimages.withfloats.com/tile/685bf1b95d6f047570824865.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-25T12:55:17.97Z", "updatedon": "2025-07-02T06:35:37.588Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rebampee-otic/2137", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rebamipide alpha lipoic acid and acetylcysteine capsules", "category": "GASTROLOGYRANGE", "tags": [ "rebamipide alpha lipoic acid and acetylcysteine capsules", "rebamipide tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6815f503b631af66ff8479d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATOVASTRIN EZ F", "description": "ATOVASTRIN EZ F is a scientifically formulated triple-action lipid-lowering medication designed for the comprehensive management of dyslipidemia and mixed hyperlipidemia. Combining Atorvastatin, Fenofibrate, and Ezetimibe, this powerful therapy targets multiple pathways of cholesterol and triglyceride metabolism. It is ideal for patients with elevated LDL cholesterol, triglycerides, and low HDL levels, helping reduce cardiovascular risk effectively.\n\nKey Ingredients\nAtorvastatin Calcium (10 mg):\nA statin that inhibits HMG-CoA reductase, reducing cholesterol production in the liver and lowering LDL (bad cholesterol) and total cholesterol levels.\n\nFenofibrate (160 mg):\nA fibrate that activates peroxisome proliferator-activated receptors (PPAR-alpha) to enhance the breakdown of triglycerides and increase HDL (good cholesterol) levels.\n\nEzetimibe IP (10 mg):\nA cholesterol absorption inhibitor that works at the intestinal level to block the absorption of cholesterol from food, further lowering blood cholesterol.\n\nKey Benefits\nComprehensive control of LDL, HDL, and triglyceride levels\n\nReduces total cholesterol and prevents the buildup of arterial plaque\n\nImproves cardiovascular outcomes in patients at high risk\n\nTargets cholesterol absorption, production, and clearance simultaneously\n\nBeneficial for patients with mixed dyslipidemia, metabolic syndrome, or diabetic dyslipidemia\n\nSupports long-term heart and blood vessel health\n\nHow Does It Work?\nATOVASTRIN EZ F works through a three-pronged mechanism to lower lipid levels:\n\nAtorvastatin blocks HMG-CoA reductase in the liver, reducing cholesterol synthesis and increasing LDL receptor activity to clear more cholesterol from the bloodstream.\n\nFenofibrate stimulates enzymes that enhance the oxidation of fatty acids and reduce triglyceride levels while increasing HDL.\n\nEzetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein in the intestine, preventing dietary and biliary cholesterol absorption.\n\nTogether, these actions reduce LDL cholesterol, raise HDL, and lower triglycerides, offering complete lipid management.\n\nDirections for Use\nTake ATOVASTRIN EZ F exactly as prescribed by your physician.\n\nTypically, one tablet is taken once daily, preferably with or after a meal.\n\nSwallow the tablet whole with water — do not crush or chew.\n\nMaintain a low-fat, heart-healthy diet and follow regular exercise for best results.\n\nRegular monitoring of lipid profile, liver function, and renal function is advised during long-term use.\n\nDo not discontinue the medication without consulting your doctor.\n\nSide Effects\nLike all medications, ATOVASTRIN EZ F may cause some side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nMuscle pain or cramps\n\nDigestive disturbances (nausea, diarrhea, indigestion)\n\nFatigue\n\nMild elevation in liver enzymes\n\nRare but Serious Side Effects:\n\nRhabdomyolysis (muscle breakdown with dark urine and weakness)\n\nLiver toxicity\n\nPancreatitis\n\nGallstones (due to fenofibrate)\n\nAllergic reactions (rash, itching, swelling)\n\nSeek medical help immediately if you experience severe muscle pain, yellowing of eyes/skin, or signs of allergic reaction.", "price": 298.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "allergic reaction", "dark urine", "renal function", "chew maintain", "meal swallow", "daily preferably", "physician typically", "fatty acids", "threepronged mechanism", "ldl hdl", "intestinal level", "comprehensive management", "triglyceride metabolism", "side effects", "atovastrin ez", "biliary cholesterol absorption", "cholesterol absorption inhibitor", "liver enzymes rare", "doctor side effects", "medications atovastrin ez", "work atovastrin ez", "reduce triglyceride levels", "results regular monitoring", "follow regular exercise", "lowfat hearthealthy diet", "intestine preventing dietary", "blood vessel health", "clearance simultaneously beneficial" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2100, "imageuri": "https://productimages.withfloats.com/actual/6815f505a654de67a62eb05a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6815f505a654de67a62eb05a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-03T10:50:43.252Z", "updatedon": "2025-05-03T10:51:38.958Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atovastrin-ez-f/2100", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Atrovastatin Calcium (10mg), Fenofibrate (160mg), Ezetimibe IP (10mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Atorvastatin 10 mg and Fenofibrate 160 mg Tablet uses", "Atorvastatin 10 mg fenofibrate 160 mg side effects", "Atorvastatin 10 mg and Fenofibrate 160 mg brands", "Atorvastatin 10 Mg and Fenofibrate 160 mg Uses in Hindi", "Atorvastatin 10 mg and Fenofibrate 160 mg Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e745ca846511e502f9489", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Fabrical D3 6L ", "description": "Fabrical D3 6L \nCholecalciferol Vitamin D3 (600,000IU) Injection\nIntroduction\nFabrical D3 6L is a potent vitamin D3 (Cholecalciferol) injection, providing 600,000 IU per dose. This high-dose formulation is designed to address severe vitamin D deficiency and support overall bone health. It is particularly useful for individuals who cannot achieve adequate vitamin D levels through oral supplements or dietary intake.\n\nComposition\n\nCholecalciferol (Vitamin D3) 600,000 IU: A fat-soluble vitamin essential for the absorption of calcium and phosphorus in the body, playing a crucial role in maintaining bone health and calcium homeostasis.\nMechanism of Action\nCholecalciferol (Vitamin D3) undergoes hydroxylation in the liver to form 25-hydroxyvitamin D, which is then converted in the kidneys to its active form, calcitriol (1,25-dihydroxyvitamin D). Calcitriol enhances the intestinal absorption of calcium and phosphorus, supports bone mineralization, and modulates immune function.\n\nIndications\nFabrical D3 6L is indicated for:\n\nSevere Vitamin D Deficiency: To rapidly correct low levels of vitamin D.\nOsteoporosis: To support bone health and prevent fractures.\nHypocalcemia: To assist in the treatment of low calcium levels due to hypoparathyroidism or other conditions.\nRickets and Osteomalacia: To treat and prevent bone disorders caused by vitamin D deficiency.\nMalabsorption Syndromes: In conditions like Crohn’s disease, celiac disease, and bariatric surgery where vitamin D absorption is impaired.\nDosage and Administration\n\nAdult Dosage: Typically, a single dose of 600,000 IU is administered intramuscularly. The frequency of administration depends on the severity of deficiency and the patient's response to treatment.\nAdministration: The injection should be administered by a healthcare professional. It is important to monitor serum calcium and vitamin D levels during treatment to avoid hypercalcemia and vitamin D toxicity.\nSide Effects\nCommon side effects may include:\n\nPain at the injection site\nMild gastrointestinal disturbances (nausea, vomiting)\nFatigue\nHeadache\nMore severe side effects can include:\n\nHypercalcemia (high calcium levels), which may present with symptoms like weakness, confusion, increased thirst and urination, and abdominal pain.\nHypervitaminosis D, resulting from excessive vitamin D intake.\nPrecautions\n\nHypercalcemia: Patients should be monitored for signs of elevated calcium levels.\nKidney Function: Use with caution in patients with renal impairment as vitamin D metabolism and excretion may be affected.\nPregnancy and Lactation: High doses of vitamin D should be used under medical supervision during pregnancy and lactation.\nDrug Interactions\n\nThiazide Diuretics: May increase the risk of hypercalcemia when used with vitamin D.\nAntiepileptic Drugs: Some antiepileptics may decrease vitamin D levels.\nGlucocorticoids: May reduce the effectiveness of vitamin D by impairing calcium absorption.\nConclusion\nFabrical D3 6L, with its high-dose Cholecalciferol (600,000 IU), provides an effective treatment for severe vitamin D deficiency and related conditions. Its ability to rapidly restore adequate vitamin D levels makes it an essential therapeutic option for individuals with significant deficiencies or those who have difficulty absorbing vitamin D. As with any high-dose supplementation, it is critical to use this medication under the guidance of a healthcare professional to ensure safety and efficacy, with regular monitoring to prevent potential side effects such as hypercalcemia and vitamin D toxicity.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "600,000 IU", "High doses", "low levels", "vitamin D.", "single dose", "active form", "Adult Dosage", "crucial role", "serum calcium", "injection site", "abdominal pain", "celiac disease", "bone disorders", "dietary intake", "Fabrical D3 6L", "Kidney Function", "immune function", "other conditions", "renal impairment", "oral supplements", "Drug Interactions", "bariatric surgery", "potent vitamin D3", "related conditions", "regular monitoring", "therapeutic option", "Thiazide Diuretics", "calcium absorption", "Hypervitaminosis D", "low calcium levels", "vitamin D toxicity", "effective treatment", "Antiepileptic Drugs", "medical supervision", "calcium homeostasis", "bone mineralization", "25-hydroxyvitamin D", "fat-soluble vitamin", "overall bone health", "high calcium levels", "Common side effects", "vitamin D absorption", "vitamin D metabolism", "intestinal absorption", "high-dose formulation", "25-dihydroxyvitamin D", "potential side effects", "healthcare professional", "Malabsorption Syndromes", "elevated calcium levels", "significant deficiencies", "More severe side effects", "high-dose Cholecalciferol", "high-dose supplementation", "adequate vitamin D levels", "Cholecalciferol Vitamin D3", "excessive vitamin D intake", "severe vitamin D deficiency", "Mild gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1934, "imageuri": "https://productimages.withfloats.com/actual/668e74610637666af0103bb2.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e74610637666af0103bb2.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:45:32.964Z", "updatedon": "2024-07-10T11:45:32.964Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fabrical-d3-6l-/1934", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Fabrical D3 6L ", "category": "GENERAL RANGE", "tags": [ "Vitamin D 600 000 IU injection dosage", "Vitamin D Injection 600 000 price in India", "Vitamin D3 injection dosage for adults", "Vitamin D Injection 600 000 dosage price", "Vitamin D Injection 600 000 brand name", "Vitamin D injection 600 000 benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e72553345171da8e569d1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 445.0, "discountamount": 133.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "Hair loss", "INR levels", "high levels", "Weight gain", "motor skills", "correct dose", "initial dose", "Liver damage", "Proper dosage", "effective use", "divided doses", "various types", "valproate ion", "valproic acid", "increased risk", "medical advice", "Concurrent use", "dosing syringe", "manic episodes", "close monitoring", "sodium valproate", "bipolar disorder", "Divalproex Sodium", "active ingredient", "Drug Interactions", "neuronal activity", "dosage adjustments", "Bleeding Disorders", "Regular monitoring", "migraine headaches", "low platelet count", "healthcare provider", "electrical activity", "Common side effects", "effective medication", "anticoagulant effect", "Migraine Prophylaxis", "various neurological", "liver function tests", "1:1 molar relationship", "psychiatric conditions", "potential side effects", "healthcare professional", "gamma-aminobutyric acid", "congenital malformations", "complex absence seizures", "complex partial seizures", "More severe side effects", "other antiepileptic drugs", "optimal clinical response", "administration instructions", "inhibitory neurotransmitter", "mood-stabilizing properties", "mood-stabilizing medication", "DIOWELPREX 250 ORAL SOLUTION", "stable coordination compound", "Gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1933, "imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:36:53.173Z", "updatedon": "2024-07-10T11:36:53.173Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-250-oral-solution-/1933", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX 250 ORAL SOLUTION ", "category": "NEUROLOGY RANGE", "tags": [ "Divalproex 250 mg", "Divalproex side effects", "Divalproex prolonged release tablets", "Divalproex extended release tablets IP 250 mg", "Divalproex prolonged release tablets uses", "Divalproex 250 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e670cc6d2d31770978860", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEFEXOTIME DICLOXA ", "description": "CEFEXOTIME DICLOXA \nCefixime (200mg), Dicloxacillin ER (500mg)\nIntroduction\nCEFEXOTIME DICLOXA is a potent antibiotic combination therapy that includes Cefixime (200mg) and Dicloxacillin ER (500mg). This medication is designed to combat a broad spectrum of bacterial infections, leveraging the synergistic effects of both antibiotics to enhance efficacy.\n\nComposition\n\nCefixime (200mg): A third-generation cephalosporin antibiotic known for its broad-spectrum activity against Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.\nDicloxacillin ER (500mg): An extended-release form of dicloxacillin, a penicillinase-resistant penicillin. It is particularly effective against penicillinase-producing staphylococci and works by inhibiting cell wall synthesis.\nMechanism of Action\n\nCefixime: It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, disrupting the cross-linking of peptidoglycan chains necessary for cell wall strength and rigidity, resulting in cell lysis.\nDicloxacillin: It similarly binds to PBPs, preventing the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, which is crucial for maintaining cell wall integrity.\nIndications\nCEFEXOTIME DICLOXA is indicated for the treatment of various bacterial infections, including:\n\nRespiratory tract infections (e.g., bronchitis, pneumonia)\nUrinary tract infections (UTIs)\nSkin and soft tissue infections\nOtitis media\nSinusitis\nBone and joint infections\nDosage and Administration\nThe typical dosage for adults is one tablet taken twice daily, with or without food. The duration of treatment depends on the severity and type of infection, usually ranging from 7 to 14 days. It is essential to complete the full course of therapy to prevent the development of antibiotic-resistant bacteria.\n\nSide Effects\nCommon side effects may include:\n\nGastrointestinal disturbances (nausea, vomiting, diarrhea)\nAllergic reactions (rash, itching, anaphylaxis in severe cases)\nPseudomembranous colitis\nHepatic dysfunction (elevated liver enzymes)\nHematologic effects (eosinophilia, neutropenia)\nRenal toxicity (in rare cases)\nPrecautions\n\nAllergy: Patients with a history of allergic reactions to cephalosporins, penicillins, or any other beta-lactam antibiotics should use this medication with caution.\nRenal Impairment: Dose adjustment may be necessary for patients with renal dysfunction.\nPregnancy and Lactation: The safety of this medication in pregnant and breastfeeding women has not been fully established. It should only be used if clearly needed and prescribed by a healthcare provider.\nDrug Interactions\n\nProbenecid: May increase blood levels of Cefixime.\nWarfarin: Concomitant use can enhance anticoagulant effects, increasing the risk of bleeding.\nMethotrexate: Cefixime may reduce renal clearance of methotrexate, increasing its toxicity.\nOral Contraceptives: Antibiotics may reduce the efficacy of oral contraceptives, suggesting the need for additional contraceptive measures.\nConclusion\nCEFEXOTIME DICLOXA, with its combination of Cefixime and Dicloxacillin, provides a robust treatment option for various bacterial infections. Its broad-spectrum efficacy, combined with the extended-release formulation, ensures a potent and convenient antibiotic therapy. As with all antibiotics, it is crucial to use this medication as prescribed and complete the full course to prevent the emergence of resistant bacteria and achieve optimal therapeutic outcomes. Always consult with a healthcare professional before starting any new medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 395.0, "discountamount": 118.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "rare cases", "one tablet", "cell lysis", "full course", "blood levels", "severe cases", "7 to 14 days", "Otitis media", "new medication", "Renal toxicity", "typical dosage", "broad spectrum", "renal clearance", "Concomitant use", "Dose adjustment", "Dicloxacillin ER", "Renal Impairment", "joint infections", "Drug Interactions", "renal dysfunction", "Allergic reactions", "CEFEXOTIME DICLOXA", "cell wall strength", "Oral Contraceptives", "healthcare provider", "breastfeeding women", "Hepatic dysfunction", "Hematologic effects", "synergistic effects", "Common side effects", "cell wall integrity", "peptidoglycan chains", "bacterial cell walls", "extended-release form", "anticoagulant effects", "Gram-negative bacteria", "soft tissue infections", "elevated liver enzymes", "broad-spectrum efficacy", "healthcare professional", "broad-spectrum activity", "peptidoglycan synthesis", "robust treatment option", "Pseudomembranous colitis", "Urinary tract infections", "penicillin-binding proteins", "final transpeptidation step", "Respiratory tract infections", "various bacterial infections", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "antibiotic-resistant bacteria", "other beta-lactam antibiotics", "convenient antibiotic therapy", "bacterial cell wall synthesis", "additional contraceptive measures", "penicillinase-resistant penicillin", "penicillinase-producing staphylococci", "potent antibiotic combination therapy", "third-generation cephalosporin antibiotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1928, "imageuri": "https://productimages.withfloats.com/actual/668e670f4e0af60ab3e5e128.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e670f4e0af60ab3e5e128.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T10:48:44.065Z", "updatedon": "2024-07-10T10:48:44.065Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefexotime-dicloxa-/1928", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEFEXOTIME DICLOXA ", "category": "GENERAL RANGE", "tags": [ "Cefixime and Dicloxacillin tablets Uses in Hindi", "Cefixime+Dicloxacillin er tablets", "", "Cefixime and Dicloxacillin uses", "Cefixime Dicloxacillin and lactic acid bacillus ta", "", "Cefixime + Dicloxacillin and Lactic acid bacillus ", "Cefixime Dicloxacillin mr and lactic acid bacillus", "Cefixime and Dicloxacillin tablets side effects", "Cefixime dicloxacillin tablet uses in tamil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66541ca7329f8d125c490814", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIDRONE 200", "description": "AMIDRONE 200\nAmiodarone (200mg)\nAMIDRONE 200, containing Amiodarone (200mg), is a highly effective antiarrhythmic medication designed to stabilize heart rhythms. It's particularly crucial for patients with potentially fatal arrhythmias where other treatments might have failed.\n\nUses:\nThis medication is primarily used to treat severe ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation. It is also effective against atrial fibrillation and other serious supraventricular arrhythmias that do not respond to other medications.\n\nDosage:\nTreatment typically starts with a high initial dose ranging from 800 to 1600 mg daily for 1 to 3 weeks until a response is achieved, followed by a gradual reduction to maintenance levels of 200 to 400 mg per day as directed by a healthcare provider.\n\nSide Effects:\nCommon side effects of AMIDRONE 200 include nausea, fatigue, and tremors. Serious potential side effects involve lung and liver toxicity, vision issues, and skin changes. Long-term use may lead to thyroid dysfunction or neurological effects.\n\nPrecautions:\nPatients on AMIDRONE 200 should have regular monitoring of heart function, liver enzymes, lung function, and thyroid function tests. This medication should be used with caution in combination with other drugs that can affect the heart rhythm. Patients should avoid grapefruit juice and excessive sunlight due to interactions and increased risk of sunburn.\n\nConclusion:\nAMIDRONE 200 is a cornerstone in the management of severe arrhythmias, requiring careful oversight and regular follow-ups to manage its complex side effect profile effectively. It's vital for patients to maintain close communication with their healthcare providers to ensure safe and effective treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 126.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "800", "day", "risk", "Uses", "safe", "200mg", "Dosage", "nausea", "1600 mg", "sunburn", "tremors", "fatigue", "AMIDRONE", "patients", "response", "Conclusion", "Amiodarone", "management", "Precautions", "combination", "cornerstone", "other drugs", "interactions", "1 to 3 weeks", "skin changes", "200 to 400 mg", "lung function", "liver enzymes", "vision issues", "heart rhythms", "Long-term use", "liver toxicity", "heart function", "grapefruit juice", "other treatments", "gradual reduction", "fatal arrhythmias", "other medications", "high initial dose", "careful oversight", "maintenance levels", "regular follow-ups", "excessive sunlight", "severe arrhythmias", "regular monitoring", "atrial fibrillation", "Common side effects", "healthcare provider", "effective treatment", "close communication", "thyroid dysfunction", "neurological effects", "thyroid function tests", "ventricular tachycardia", "ventricular fibrillation", "complex side effect profile", "Serious potential side effects", "severe ventricular arrhythmias", "effective antiarrhythmic medication", "other serious supraventricular arrhythmias" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1154, "imageuri": "https://productimages.withfloats.com/actual/667d2d5d000f6c164f095062.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2d5d000f6c164f095062.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-27T05:39:51.591Z", "updatedon": "2024-06-27T09:14:03.7Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amidrone-200/1154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Amiodarone (200mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Amiodarone 200 mg uses", "Amiodarone uses", "Amiodarone dosage 200 mg", "Is 200 mg of amiodarone a lot", "Amiodarone 200 mg price", "Amiodarone side effects", "Side effects of amiodarone 200 mg", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6634cc9d4194481fc81fe331", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CYCLOPURE 100 ", "description": "CYCLOPURE 100 \nCyclosporine (100mg)\nCyclopure 100 is a medication containing 100mg of Cyclosporine, an immunosuppressant drug. It is primarily used to prevent organ rejection in transplant recipients. Cyclosporine works by suppressing the immune system's response, thereby reducing the risk of the body rejecting a transplanted organ.\n\nDrug Class: Immunosuppressant\nDosage Form: Oral Capsules\nComposition: Each capsule contains 100mg of Cyclosporine.\nIndications: Cyclopure 100 is indicated for the prevention of organ rejection in kidney, liver, and heart transplant patients. It is also used in the treatment of certain autoimmune diseases like rheumatoid arthritis and psoriasis.\nDosage and Administration: The dosage of Cyclopure 100 varies based on the patient's transplant type and individual response. It is typically administered orally once or twice daily, as directed by a healthcare professional.\nContraindications: Cyclopure 100 should not be used in patients with known hypersensitivity to Cyclosporine or any of its components. It is contraindicated in patients with uncontrolled hypertension or malignancies.\nSide Effects: Common side effects may include headache, nausea, vomiting, diarrhea, high blood pressure, and increased risk of infections. Serious side effects like kidney problems and liver toxicity may occur in some cases.\nPrecautions: Patients taking Cyclopure 100 should be monitored regularly for kidney function, blood pressure, and signs of infections. It may interact with certain medications, so a healthcare provider should be informed about all medications being taken.\nStorage: Store Cyclopure 100 capsules at room temperature, away from moisture and heat.\nCyclopure 100 requires a prescription and should only be used under the supervision of a qualified healthcare professional.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 1274.0, "discountamount": 383.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "heat", "body", "risk", "100mg", "signs", "cases", "nausea", "Storage", "diarrhea", "vomiting", "headache", "moisture", "psoriasis", "treatment", "infections", "Drug Class", "components", "prevention", "medication", "Indications", "Precautions", "supervision", "malignancies", "Cyclosporine", "prescription", "immune system", "Administration", "liver toxicity", "kidney function", "organ rejection", "transplant type", "kidney problems", "hypersensitivity", "room temperature", "autoimmune diseases", "individual response", "Common side effects", "healthcare provider", "high blood pressure", "rheumatoid arthritis", "Serious side effects", "transplant recipients", "immunosuppressant drug", "Cyclopure 100 capsules", "uncontrolled hypertension", "heart transplant patients", "Oral Capsules Composition", "Immunosuppressant Dosage Form", "qualified healthcare professional" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1061, "imageuri": "https://productimages.withfloats.com/actual/6634cca7085b40e38314d711.png", "tileimageuri": "https://productimages.withfloats.com/tile/6634cca7085b40e38314d711.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-03T11:38:05.78Z", "updatedon": "2024-06-12T11:08:27.601Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cyclopure-100-/1061", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cyclosporine (100mg)", "category": "ORTHOLOGYRANG", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }